LipidAssociation,NLA)以及美国心血管预防护理学会反映了冠状动脉疾病患者从急性到慢性的连续过程,适 (PreventiveCardiovascularNursesAssociation,PCNA)用于门诊环境中。同时有益于指导我国基层医疗卫生机 联合发布了《2023AHA/ACC/ACCP/ASPC/NLA/PCNA慢构全科医生对冠状动脉疾病的整体性认知,以及制订综 性冠状动脉疾病患者管...
尽管2023年中国血脂管理指南已明确提出将LDL-C“双达标”(<1.4 mmol/L且较基线降幅≥50%)作为超高危患者的治疗目标,但真实世界数据显示,绝大多数患者仍停留在单药他汀的治疗阶段,治疗强度不足,达标率低。一项多中心真实世界研究[2]显示...
Impact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelinesImpact of new lipid management guidelines on the treatment of extreme and very high‐risk patients: AACE/ACE and AHA/ACC guidelinesTRANSIENT ischemic attackANKLE...
The recently published 2013 ACC/AHA guidelines for the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk seem to have various implementation problems and have already initiated an intens...
December 04, 20230Guidelines on the management of patients with chronic coronary disease (CCD) were published in July 2023 by the American Heart Association (AHA), the American College of Cardiology (ACC), and other specialty societies, published in Circulation.[1,2] These recommendations take ...
AHA-LP(A)队列中黑人与白人测量脂蛋白(A)后的降脂治疗滴定 PHYSICIAN PRESCRIBING PATTERNS, PERCEPTIONS AND KNOWLEDGE AROUND LIPID LOWERING GUIDELINES 医生关于降脂指南的处方模式、认知和知识 SMALL DENSE LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND CORONARY...
ACC/AHA Clinical Practice Guidelines percutaneous coronary intervention (PCI) angioplasty coronary artery bypass graft (CABG) surgery myocardial infarction cardiac surgery stent(s) angiogram angiography percutaneous transluminal coronary angioplasty coronary atherosclerosis saphenous vein graft internal mammary artery...
ContextThe joint cardiovascular practice guidelines of the American College of Cardiology (ACC) and the American Heart Association (AHA) have become
In addition, the mean change in maximum lipid core burden index within 4 mm was -79.42 in the alirocumab group compared with -37.60 in the placebo group, while the mean change in minimal fibrous cap thickness was 62.67 μm with alirocumab vs. 33.19 μm with placebo. Adverse events were ...
Percentage among those recommended add-on lipid-lowering therapy 5.2 % (95 % CI, 1.9 % - 8.6 %) Abbreviations: AHA/ACC - American Heart Association/American College of Cardiology, ASCVD - atherosclerotic cardiovascular disease, CI - Confidence Interval, LDL - low-density lipoprotein,...